December 2009 Volume 44 Number 12, pp 769 - 828
---------------------------------------------------------------------
Why choose Bone Marrow Transplantation for your research?
Submit your research online at
http://links.ealert.nature.com/ctt?kn=52&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
and benefit from the wide readership that nature.com has to offer,
allowing your paper to be identified with all other relevant Nature
Publishing Group articles in keyword searches.
Rapid publication is assured through Advance Online
Publication - articles are published online within 25 days of
acceptance - and inclusion in the leading abstracting and indexing
services is guaranteed.
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=61&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
to start your subscription today.
----------------------
REVIEW
----------------------
Management of relapse after allo-SCT for AML and the role of second
transplantation
B N Savani, S Mielke, N Reddy, S Goodman, M Jagasia and K Rezvani
Abstract: http://links.ealert.nature.com/ctt?kn=6&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=31&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Mobilization of PBSCs with chemotherapy and recombinant human G-CSF:
a randomized evaluation of early vs late administration of recombinant
human G-CSF
T Ozcelik, P Topcuoglu, M Beksac, M Ozcan, M Arat, Z Biyikli, S M Bakanay,
O Ilhan, G Gurman, O Arslan and T Demirer
Abstract: http://links.ealert.nature.com/ctt?kn=29&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=33&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Fludarabine, amsacrine, high-dose cytarabine and 12[thinsp]Gy total body
irradiation followed by allogeneic hematopoietic stem cell transplantation
is effective in patients with relapsed or high-risk acute lymphoblastic
leukemia
F Zohren, A Czibere, I Bruns, R Fenk, T Schroeder, T Graf, R Haas and
G Kobbe
Abstract: http://links.ealert.nature.com/ctt?kn=32&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=23&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Effect of iron overload and iron-chelating therapy on allogeneic
hematopoietic SCT in children
J W Lee, H J Kang, E K Kim, H Kim, H Y Shin and H S Ahn
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Early lymphocyte recovery after allogeneic hematopoietic SCT is associated
with significant GVL effect in pediatric ALL but not acute myelogenous
leukemia[mdash]Update study
S Afzal, M K Ishaqi, A Dupuis, J Doyle and A Gassas
Abstract: http://links.ealert.nature.com/ctt?kn=28&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=44&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Clinical and immunologic outcomes following haplocompatible donor
lymphocyte infusions
C C Dvorak, A L Gilman, B Horn, J Jaroscak, E A Dunn, L A Baxter-Lowe
and M J Cowan
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=42&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Skin response using NIH consensus criteria vs Hopkins scale in a phase
II study for steroid-refractory chronic GVHD
D A Jacobsohn, A Rademaker, M Kaup and G B Vogelsang
Abstract: http://links.ealert.nature.com/ctt?kn=53&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=51&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT
D Z Drew, T Donohue, C Ramos, L Cook, R Goodwin, N Patronas, D Arrington,
M Ramanathan and R Childs
http://links.ealert.nature.com/ctt?kn=49&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Palifermin, a recombinant human keratinocyte growth factor, triggers
reactivation of anogenital human papillomavirus infection in a HIV-positive
patient with diffuse large cell B-cell non-Hodgkin lymphoma
T Schroeder, F Zohren, C Saure, G Kobbe and R Haas
http://links.ealert.nature.com/ctt?kn=47&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Ethmoiditis-associated apex syndrome may result in temporary blindness
after allo-SCT
R Olsson, J-E Juto and J Mattsson
http://links.ealert.nature.com/ctt?kn=21&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
Detection of extra-medullary relapse of acute lymphoblastic leukemia
by radiographic imaging following allogeneic hematopoietic SCT
J Francis, S Smiley, M Battiwalla, M Wetzler, M Barcos, W Bshara,
P Paplham, K Brown, M Syta, D Lamonica, P Loud and P McCarthy
http://links.ealert.nature.com/ctt?kn=26&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
---------------------------------------------------------------------
Free Table of Contents E-alerts - directly to your desktop
Table of Contents E-alerts are a quick and easy way to stay
up-to-date on the latest research, reviews and clinical trials in
molecular medicine and gene therapy published regularly in Molecular
Therapy. Enjoy all the benefits of the only journal ranked within the
top 20 in Genetics, Medicine and Biotechnology delivered directly to
your inbox - at no charge! Visit the journal online at
http://links.ealert.nature.com/ctt?kn=9&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
to learn more.
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=56&m=34511542&r=MTc1NjE0NTQ4OQS2&b=2&j=NjI5NTAxNjAS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
